Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts)

被引:0
|
作者
Rossi, Luigi
Tomao, Federica
Papa, Anselmo
Zoratto, Federica
Ricci, Fabio
Spinelli, Gian Paolo
Lo Russo, Giuseppe
Basso, Enrico
Caprio, Giuliana
Barberi, Simona
Verrico, Monica
Giordani, Erika
Zaccarelli, Eleonora
Rinaldi, Giulia
Stati, Valeria
Pasciuti, Giulia
Strudel, Martina
Tomao, Silverio
机构
[1] Univ Rome, Santa Maria Goretti Hosp, Dept Medicosurg Sci & Biotechnol, Oncol Unit, Latina, Italy
[2] Dept Gynecol & Obstet, Rome, Italy
[3] Osped SM Goretti, Latina, Italy
[4] Univ Rome, Dept Expt Med & Pathol, Rome, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e11514
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Evaluation of clinical cardiotoxicity of nonpegylated liposomal doxorubicin in the treatment of patients with metastatic breast cancer (MBC) who had received prior adjuvant anthracyclines
    Serrano, C.
    Munoz, E.
    Brana, I.
    Martinez, P.
    Saura, C.
    Quispe, I. R.
    Atzori, F.
    Gomez, P.
    Calvo-Aller, E.
    Cortes, J. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Phase II study of neoadjuvant docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer (LABC)
    Perez-Manga, G.
    Mendez, M.
    Palomero, M. I.
    Quiben, R.
    Belon, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Phase II study of capecitabine (X) plus docetaxel (T) as neoadjuvant treatment in patients (pts) with locally advanced breast cancer (LABC) including biological correlates.
    Bellet, M.
    Muñoz, M.
    Bellosillo, B.
    Corominas, J.
    Pena, T.
    Suárez, M.
    Maristany, M.
    Perich, J.
    Tusquets, I.
    Fabregat, X.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 43S - 43S
  • [34] Metronomic scheduling of pegylated liposomal doxorubicin (PLA) for the palliative treatment of patients with advanced breast cancer (ABC)
    Verri, E.
    Nole, F.
    Sanna, G.
    Cossu, Rocca M.
    Munzone, E.
    Catania, C.
    Ascione, G.
    Adamoli, L.
    Dellapasqua, S.
    Colleoni, M.
    Goldhirsch, A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI10 - XI10
  • [35] Pegylated liposomal doxorubicin as neoadjuvant therapy for stage II-III locally advanced breast cancer
    Yao, Jia
    Pan, Shaobo
    Fan, Xiao
    Jiang, Xue
    Yang, Yuhong
    Jin, Jing
    Liu, Yu
    [J]. JOURNAL OF CHEMOTHERAPY, 2020, 32 (04) : 202 - 207
  • [36] Phase II Study of Neoadjuvant Gemcitabine, Pegylated Liposomal Doxorubicin, and Docetaxel in Locally Advanced Breast Cancer
    Grazia, Artioli
    Simone, Mocellin
    Lucia, Borgato
    Alessandro, Cappetta
    Fernando, Bozza
    Giorgio, Zavagno
    Stefania, Zovato
    Alberto, Marchet
    Davide, Pastorelli
    [J]. ANTICANCER RESEARCH, 2010, 30 (09) : 3817 - 3821
  • [37] A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer
    Vujaskovic, Zeljko
    Kim, Dong W.
    Jones, Ellen
    Lan, Lan
    Mccall, Linda
    Dewhirst, Mark W.
    Craciunescu, Oana
    Stauffer, Paul
    Liotcheva, Vlayka
    Betof, Allison
    Blackwell, Kimberly
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2010, 26 (05) : 514 - 521
  • [38] A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel and hyperthermia in locally advanced breast cancer
    Kim, D. W.
    Blackwell, K.
    Vujaskovic, Z.
    Craciunescu, O.
    Stauffer, P.
    Liotcheva, V.
    Jones, E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S183 - S184
  • [39] Efficiency of liposomal doxorubicin in the treatment of advanced breast cancer after completed conventional doxorubicin cumulative dose
    Tomala, Michal
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 : A37 - A39
  • [40] NEOADJUVANT CHEMOTHERAPY (NAC) WITH DOCETAXEL AND LIPOSOME-ENCAPSULATED DOXORUBICIN IN LOCALLY ADVANCED HER2-BREAST CANCER (LABC)
    Merlano, M. C.
    Airoldi, M.
    Pedani, F.
    Contu, V.
    Margiotta, C.
    Fiore, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 102 - 102